The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Listing of company on the NASDAQ OMX Stockholm
Advised in connection with the listing of a Swedish company on the  NASDAQ OMX Stockholm.  The firm also represented the company in the acquisition more
Sale of telecommunications and entertainment company to venture capital fund
Represent telecommunications and entertainment company as seller's counsel in connection with the company's sale to a venture capital/investment fund. more
Project Counsel to the School District of Greenville County, South Carolina in Connection With U.S. $1 Billion Fast-Track Renovation and New School Development Program
Project counsel to the Greenville County, South Carolina School District in connection with its innovative U.S. $1 billion plan to design and more
Acquisition for a developer of commercial and residential properties
The firm served as lead counsel in the acquisition for a developer of commercial and residential properties. more